Wellness Therapy, Wichita, KS
US$ 23.19
eli lilly glp-1 products stock soars on encouraging results for daily weight-loss pill FDA grants speedy approval to
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Liu J, Pang ZP
doi: 10.20960/nh.02746
In mid to late 2025, around 12.4% of US adults reported taking a GLP-1 medicine specifically for weight loss, up from 5.8% in February 2024, according to Gallup survey data of more than 15,000 adults
The analysis also revealed sex-specific differences
This is how you can introduce your patient to GLP-1 therapy, integrating it thoughtfully into a comprehensive weight management plan for safe and sustainable results
Try Blinkist to get the key ideas from 7,500+ bestselling nonfiction titles and podcasts
